Epocrates, Inc. (NASDAQ:EPOC)

CAPS Rating: No stars

Caps

How do you think EPOC will perform against the market?

Add Stock to CAPS Watchlist

All Players

27 Outperform
2 Underperform
 

All-Star Players

6 Outperform
0 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top EPOC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFIPO2011 (< 20)
Submitted July 06, 2011

**Physicians love Epocrates' mobile applications, because they reduce prescription errors, improve patient care, and save time.**Epocrates is disrupting the face-to-face sales model used by pharma companies by offering a more targeted and… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

EPOC VS S&P 500 (SPY)

EPOC Summary

Fools bullish on EPOC are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about EPOC.

Recs

0
Member Avatar modestus1 (< 20) Submitted: 9/2/2012 3:54:41 PM : Outperform Start Price: $8.88 EPOC Score: -52.17

Undervalued based on assets.

Recs

0
Member Avatar jrawk28 (23.21) Submitted: 1/15/2012 12:39:08 PM : Outperform Start Price: $8.90 EPOC Score: -67.99

Huge potential for future revenue, but so far untapped. 2013-2014 things should pick up as they capitalize on their user base of 50% of US physicians, the most valuable customers in the world.

Recs

1
Member Avatar TMFIPO2011 (< 20) Submitted: 7/6/2011 1:21:55 PM : Outperform Start Price: $17.57 EPOC Score: -138.85

**Physicians love Epocrates' mobile applications, because they reduce prescription errors, improve patient care, and save time.
**Epocrates is disrupting the face-to-face sales model used by pharma companies by offering a more targeted and cost-effective way to introduce physicians to new and existing drugs.
**The company has ridden its first-mover advantage to an 80% market share that reaches 45% of all U.S. physicians, and it benefits from a recurring revenue base to fund R&D for new products.

Leaderboard

Find the members with the highest scoring picks in EPOC.

Score Leader

04redsox

04redsox (< 20) Score: +145.08

The Score Leader is the player with the highest score across all their picks in EPOC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
04redsox < 20 4/14/2011 Underperform 5Y $21.79 -46.17% +98.84% +145.01 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. multicharts < 20 8/29/2012 Underperform 5Y $8.75 +34.13% +83.64% +49.51 0 Comment
Darvo285 < 20 12/31/2012 Outperform 5Y $8.71 +34.67% +86.09% -51.41 0 Comment
modestus1 < 20 9/4/2012 Outperform 5Y $8.88 +32.09% +84.27% -52.17 1 Comment
jrawk28 23.21 1/17/2012 Outperform 5Y $8.90 +31.80% +99.79% -67.99 1 Comment
super72 84.75 11/4/2011 Outperform 5Y $8.45 +38.82% +108.40% -69.58 0 Comment
Arrico 87.80 10/31/2011 Outperform 5Y $8.71 +34.67% +104.93% -70.25 0 Comment
giantcreek 21.26 12/1/2011 Outperform 1Y $8.54 +37.35% +108.16% -70.81 0 Comment
SMGERMAN100 23.65 1/8/2013 Outperform 5Y $11.69 +0.34% +78.20% -77.85 0 Comment
adamsdad123 < 20 1/8/2013 Outperform 5Y $11.68 +0.43% +78.36% -77.93 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRaymondJame 92.54 9/25/2012 Outperform NS $11.12 +5.49% +78.06% -72.57 0 Comment
TrackMorganKeeg 72.77 8/11/2011 Outperform NS $10.48 +11.93% +129.46% -117.54 0 Comment

Featured Broker Partners

</